Zobrazeno 1 - 10
of 275
pro vyhledávání: ''
Autor:
Xiaohong Pan, Lei Pan, Minjie Mao, Xiao-bo Ji, Xiao-qing Huang, Caihong Wang, Junke Qiu, Yang Zhou, Jiekun Xu
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Disseminated nocardiosis is liable to be misdiagnosed owing to the non-specific clinical manifestations and laboratory/imaging findings. Metagenomic next-generation sequencing (mNGS) is a culture-independent and rapid method for direct ide
Autor:
Adwoa K. A. Afrane, Seth Agyeman, Yakubu Alhassan, Seth N. Owiafe, Kwamena W. Sagoe, Bamenla Q. Goka, Alfred Yawson, Lorna Renner, Awewura Kwara
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Children living with human immunodeficiency virus (HIV) infection require lifelong effective antiretroviral therapy (ART). The goal of ART in HIV-infected persons is sustained viral suppression. There is limited information on virological
Autor:
Fernando Achinelli, Gerardo Andino, Maria Bangher, Paola Itati Reynoso, Antonia Cristina Aquino, Jorge Ojeda, Silvana Dellamea, Victor Flores, María Gabriela Aguirre, Elba Meza, Carolina N. Martemucci, Pablo Kawerin, Fabian Plano, Mariana Elizabeth Robledo, Claudia Campias, Hector Andres Guglielmone, Noelia Carolina Sosa, Evangelina Chaparro Campias, Rodrigo Zoni, Maria Mercedes Vernengo, Silvina Maria Martinez, Joaquina Maria Guarrochena, Natalia E. Ruiz Diaz, Diego Farizano Salazar, Julio Vallejos, Maria Fernanda Medina, Angelina Bobadilla, Silvina Villamandos, Juan Emanuel Segovia
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. Objective
Autor:
Grahame Mtui, Semvua B. Kilonzo, Paulina M. Manyiri, Daniel W. Gunda, Fredrick Kalokola, Elichilia R. Shao, Fatma A. Bakshi, Hyasinta Jaka, Alex Stephano, David C. Majinge
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Methadone therapy clinics have been recently introduced in Tanzania, aiming at reducing risk behaviors and infection rates of viral hepatitis and HIV among people who use drugs. The objective of this study was to estimate the prevalence, a
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Antibiotic-resistance reduces the efficacy of conventional triple therapy for Helicobacter Pylori infections worldwide, which necessitates using various treatment protocols. We used two protocols, doxycycline-based quadruple regimen and co
Autor:
Daniel Golparian, Tatyana Golubovskaya, Iryna Boiko, Magnus Unemo, Aliaksandra Aniskevich, Iryna Stanislavova, Aliaksandr Adaskevich, Iryna Shimanskaya, Susanne Jacobsson
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Limited antimicrobial resistance (AMR) data for Neisseria gonorrhoeae are available in Eastern Europe. We investigated AMR in N. gonorrhoeae isolates in the Republic of Belarus from 2009 to 2019, antimicrobial treatment recommended nationa
Autor:
Ayşegül Karalezli, Nurullah Okumuş, Fatma Eser, Rıza Aytaç Çetinkaya, Semiha Orhan, İsmail Yaşar Avcı, Neşe Demirtürk, Umit Savasci, Bengü Şaylan, Levent Yamanel, Petek Konya, Gürhan Taşkin, Rahmet Guner, Bircan Kayaaslan, Gulden Yilmaz
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background and objectives An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness in treatment has been
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Lower respiratory tract infection is a global problem accounting over 50 million deaths annually. Here, we determined the bacterial profile and antimicrobial susceptibility pattern of lower respiratory tract infections among adult patients
Autor:
Azadeh Afshin, Pourya Yarahmadi, Sayed Yousef Mojtahedi, Mohsen Jafari, Payman Sadeghi, Leila Khedmat, Effat Hosseinali Beigi, Anahita Izadi
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
BackgroundKawasaki disease (KD) as an acute, systemic vasculitis is the leading cause of acquired heart disease in children under the age of 5 years.MethodsA 10-year cross-sectional retrospective study was designed to assess 190 Iranian children with
Autor:
Chloe Lanyon, Victoria Hall, C. Orla Morrissey, N. Deborah Friedman, Andrew Fuller, Eugene Athan, Caroline Bartolo
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-4 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significant glycosuria and increased risk of genital mycotic infections (GMI).